Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 109
Filter
1.
mBio ; 13(3): e0091822, 2022 06 28.
Article in English | MEDLINE | ID: mdl-35608298

ABSTRACT

Trichomonas vaginalis can host the endosymbiont Mycoplasma hominis, an opportunistic pathogenic bacterium capable of modulating T. vaginalis pathobiology. Recently, a new noncultivable mycoplasma, "Candidatus Mycoplasma girerdii," has been shown to be closely associated with women affected by trichomoniasis, suggesting a biological association. Although several features of "Ca. M. girerdii" have been investigated through genomic analysis, the nature of the potential T. vaginalis-"Ca. M. girerdii" consortium and its impact on the biology and pathogenesis of both microorganisms have not yet been explored. Here, we investigate the association between "Ca. M. girerdii" and T. vaginalis isolated from patients affected by trichomoniasis, demonstrating their intracellular localization. By using an in vitro model system based on single- and double-Mycoplasma infection of Mycoplasma-free isogenic T. vaginalis, we investigated the ability of the protist to establish a relationship with the bacteria and impact T. vaginalis growth. Our data indicate likely competition between M. hominis and "Ca. M. girerdii" while infecting trichomonad cells. Comparative dual-transcriptomics data showed major shifts in parasite gene expression in response to the presence of Mycoplasma, including genes associated with energy metabolism and pathogenesis. Consistent with the transcriptomics data, both parasite-mediated hemolysis and binding to host epithelial cells were significantly upregulated in the presence of either Mycoplasma species. Taken together, these results support a model in which this microbial association could modulate the virulence of T. vaginalis. IMPORTANCE T. vaginalis and M. hominis form a unique case of endosymbiosis that modulates the parasite's pathobiology. Recently, a new nonculturable mycoplasma species ("Candidatus Mycoplasma girerdii") has been described as closely associated with the protozoon. Here, we report the characterization of this endosymbiotic relationship. Clinical isolates of the parasite demonstrate that mycoplasmas are common among trichomoniasis patients. The relationships are studied by devising an in vitro system of single and/or double infections in isogenic protozoan recipients. Comparative growth experiments and transcriptomics data demonstrate that the composition of different microbial consortia influences the growth of the parasite and significantly modulates its transcriptomic profile, including metabolic enzymes and virulence genes such as adhesins and pore-forming proteins. The data on modulation from RNA sequencing (RNA-Seq) correlated closely with those of the cytopathic effect and adhesion to human target cells. We propose the hypothesis that the presence and the quantitative ratios of endosymbionts may contribute to modulating protozoan virulence. Our data highlight the importance of considering pathogenic entities as microbial ecosystems, reinforcing the importance of the development of integrated diagnostic and therapeutic strategies.


Subject(s)
Mycoplasma , Trichomonas Infections , Trichomonas vaginalis , Ecosystem , Female , Humans , Mycoplasma/genetics , Mycoplasma hominis/genetics , Trichomonas Infections/microbiology , Trichomonas vaginalis/genetics
2.
PLoS One ; 15(12): e0242227, 2020.
Article in English | MEDLINE | ID: mdl-33264307

ABSTRACT

BACKGROUND: Information about the use of flow cytometry in the diagnosis of male urethritis is scarce. The current study aims to evaluate the performance of flow cytometry on first-voided urine in males with infectious urethritis (Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium and Trichomonas vaginalis). METHODS: Male patients of the Andrology Centre (Tartu University Hospital, Estonia) were recruited during the period March 2015 -January 2018. Cases included 306 patients with infectious urethritis caused by Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium and/or Trichomonas vaginalis. The control group consisted of 192 patients without uro-genital complaints, negative tests for C. trachomatis, N. gonorrhoeae, M. genitalium and T. vaginalis from first-voided urine and no inflammation in first-voided urine, mid-stream urine and urine after prostate massage. C. trachomatis, N. gonorrhoeae, M. genitalium and T. vaginalis were detected from first-voided urine using polymerase chain reaction (PCR) method. First-voided urine was analysed using urine particle analyzer Sysmex UF-500i. RESULTS: The most prevalent infection was chlamydia (64.1%), followed by Mycoplasma genitalium (20.9%), gonorrhoea (7.8%) and trichomoniasis (1.6%). Gonorrhoea caused the highest flow-cytometric leucocyte/bacteria count, followed by chlamydia and Mycoplasma genitalium. Trichomonas vaginalis showed nearly absent inflammation in first-voided urine. Using an empiric flow-cytometry diagnostic threshold for urethritis in first-voided urine (leucocytes ≥ 15/µl and bacteria ≥ 20/µl) the total calculated sensitivity was over 90%. However, when applying such criteria for deciding whether to perform first-voided urine PCR for C. trachomatis, N. gonorrhoeae, M. genitalium and T. vaginalis or not, we could miss 23 cases with infectious urethritis that makes up 7,5% of all proven cases. CONCLUSIONS: Flow cytometry of first-voided urine can be considered as a rapid and objective screening method in case of suspected male infectious urethritis.


Subject(s)
Heterosexuality , Inflammation/urine , Sexually Transmitted Diseases/urine , Urethritis/urine , Adolescent , Adult , Body Fluids/microbiology , Chlamydia Infections/complications , Chlamydia Infections/microbiology , Chlamydia Infections/urine , Chlamydia trachomatis/pathogenicity , Estonia/epidemiology , Gonorrhea/complications , Gonorrhea/microbiology , Gonorrhea/urine , Humans , Inflammation/etiology , Inflammation/pathology , Male , Middle Aged , Mycoplasma Infections/complications , Mycoplasma Infections/microbiology , Mycoplasma Infections/urine , Mycoplasma genitalium/pathogenicity , Neisseria gonorrhoeae/pathogenicity , Sexually Transmitted Diseases/complications , Sexually Transmitted Diseases/microbiology , Trichomonas Infections/complications , Trichomonas Infections/microbiology , Trichomonas Infections/urine , Trichomonas vaginalis/pathogenicity , Urethritis/etiology , Urethritis/microbiology , Urethritis/pathology , Young Adult
3.
Sci Rep ; 10(1): 19978, 2020 11 17.
Article in English | MEDLINE | ID: mdl-33203893

ABSTRACT

Pigeons, as the only altricial birds in poultry, are the primary Trichomonas gallinae (T. gallinae) host. To study the effects of T. gallinae infection on gut microbiota, we compared the microbiota diversity and composition in gastrointestinal (GI) tracts of pigeons at the age of 14 and 21 day with different degrees of T. gallinae infection. Thirty-six nestling pigeons were divided into three groups: the healthy group, low-grade and high-grade trichomonosis group. Then, the crop, small intestine and rectum contents were obtained for sequencing of the 16S rRNA gene V3-V4 hypervariable region. The results showed that the microbiota diversity was higher in crop than in small intestine and rectum, and the abundance of Lactobacillus genus was dominant in small intestine and rectum of healthy pigeons at 21 days. T. gallinae infection decreased the microbiota richness in crop at 14 days. The abundance of the Firmicutes phylum and Lactobacillus genus in small intestine of birds at 21 days were decreased by infection, however the abundances of Proteobacteria phylum and Enterococcus, Atopobium, Roseburia, Aeriscardovia and Peptostreptococcus genus increased. The above results indicated that crop had the highest microbiota diversity among GI tract of pigeons, and the gut microbiota diversity and composition of pigeon squabs were altered by T. gallinae infection.


Subject(s)
Columbidae/microbiology , Columbidae/parasitology , Gastrointestinal Microbiome/genetics , Gastrointestinal Microbiome/physiology , Trichomonas/parasitology , Animals , Bird Diseases/microbiology , Bird Diseases/parasitology , Firmicutes/genetics , Genotype , Lactobacillus/genetics , Phylogeny , RNA, Ribosomal, 16S/genetics , Trichomonas Infections/microbiology , Trichomonas Infections/parasitology
4.
Curr Drug Targets ; 21(16): 1672-1686, 2020.
Article in English | MEDLINE | ID: mdl-32753007

ABSTRACT

Female genital tract infections have a high incidence among different age groups and represent an important impact on public health. Among them, vaginitis refers to inflammation of the vulva and/or vagina due to the presence of pathogens that cause trichomoniasis, bacterial vaginosis, and vulvovaginal candidiasis. Several discomforts are associated with these infections, as well as pregnancy complications and the facilitation of HIV transmission and acquisition. The increasing resistance of microorganisms to drugs used in therapy is remarkable, since women report the recurrence of these infections and associated comorbidities. Different resistant mechanisms already described for the drugs used in the therapy against Trichomonas vaginalis, Candida spp., and Gardnerella vaginalis, as well as aspects related to pathogenesis and treatment, are discussed in this review. This study aims to contribute to drug design, avoiding therapy ineffectiveness due to drug resistance. Effective alternative therapies to treat vaginitis will reduce the recurrence of infections and, consequently, the high costs generated in the health system, improving women's well-being.


Subject(s)
Drug Resistance, Microbial/physiology , Vaginitis/drug therapy , Animals , Anti-Infective Agents/pharmacology , Anti-Infective Agents/therapeutic use , Candidiasis, Vulvovaginal/drug therapy , Candidiasis, Vulvovaginal/microbiology , Female , Humans , Trichomonas Infections/drug therapy , Trichomonas Infections/microbiology , Trichomonas vaginalis/drug effects , Trichomonas vaginalis/microbiology , Vaginitis/microbiology
6.
Rev Chilena Infectol ; 36(3): 292-298, 2019 Jun.
Article in Spanish | MEDLINE | ID: mdl-31859747

ABSTRACT

BACKGROUND: Pregnant woman is exposed to many sexual transmitted infections (STI). Many of these infections may produce diseases in the fetus and newborn, and also alteration in the normal course of the pregnancy. AIM: Screening of asymptomatic cervical infection in pregnant woman and its relationship with the vaginal microbiota. PATIENTS AND METHODS: 85 pregnant women without clinical cervicitis who consult in the routine pregnant control (47 patients) and women derived from STI service (38 patients). The samples were obtained from the vaginal fund sac and were analyzed with optic microscopy, cultures and PCR of Neisseria gonorrhoeae, Trichomonas vaginalis and Chlamydia trachomatis. RESULTS: 12,9% of the enrolled women were positive for C. trachomatis, 2,4% for T. vaginalis. In this study, we did not found N. gonorrhoeae. We observed 23,3% of patients with altered microbiota (bacterial vaginosis and intermediate microbiota) was positive for C. trachomatis. CONCLUSIONS: In this study, we found a high frequency of C. trachomatis infection, that correlates with the presence of altered microbiota. This high frequency would promote preventive strategies in the pregnant women routine controls.


Subject(s)
Chlamydia Infections/microbiology , Chlamydia trachomatis/isolation & purification , Sexually Transmitted Diseases/diagnosis , Trichomonas Infections/microbiology , Trichomonas vaginalis/isolation & purification , Vagina/microbiology , Adolescent , Adult , Age Distribution , Asymptomatic Infections , Chlamydia Infections/diagnosis , Female , Humans , Mass Screening , Microbiota , Pregnancy , Pregnancy Complications, Infectious/diagnosis , Pregnancy Complications, Infectious/microbiology , Sexually Transmitted Diseases/microbiology , Socioeconomic Factors , Trichomonas Infections/diagnosis , Young Adult
7.
BMC Infect Dis ; 19(1): 512, 2019 Jun 10.
Article in English | MEDLINE | ID: mdl-31182037

ABSTRACT

BACKGROUND: The methods routinely used to detect trichomonads in the lungs are not sensitive enough, and an effective method is urgently needed. METHOD: Primers were first designed to match the conserved area of the 18S rRNA gene of trichomonads. Then, nested PCR was carried out to detect trichomonads in bronchoalveolar lavage fluid (BALF). Finally, all positive specimens were subjected to DNA sequencing and phylogenetic analysis. RESULTS: Among 115 bronchoalveolar lavage fluid samples, ten samples tested positive in nested PCR (10/115), while no samples were positive in wet mount microscopy (0/115) (P < 0.01). Among the ten positive specimens, two were identified as Tetratrichomonas spp. and the other eight as Trichomonas tenax in phylogenetic analysis. CONCLUSIONS: Nested PCR is an effective way to detect trichomonads in bronchoalveolar lavage fluid.


Subject(s)
Bronchoalveolar Lavage Fluid/microbiology , Polymerase Chain Reaction/methods , Trichomonas/genetics , DNA/chemistry , DNA/metabolism , Humans , Phylogeny , Sequence Analysis, DNA , Trichomonas/classification , Trichomonas/isolation & purification , Trichomonas Infections/diagnosis , Trichomonas Infections/microbiology
8.
Rev. chil. infectol ; 36(3): 292-298, jun. 2019. tab
Article in Spanish | LILACS | ID: biblio-1013786

ABSTRACT

Resumen Introducción: La mujer embarazada está expuesta anumerosas infecciones de transmisión sexual (ITS), las que pueden producir aborto, enfermedad en el feto y/o en el recién nacido, además de alteraciones en el curso normal del embarazo. Objetivo: Realizar tamizaje de infección cervical asintomática en mujeres embarazadas y su relación con la microbiota. Pacientes y Métodos: Se enrolaron 85 mujeres embarazadas sin cervicitis clínica que consultaron en control de rutina de embarazo (47 pacientes) o que fueron derivadas a una unidad de ITS (38 pacientes). Se tomaron muestras de fondo de saco vaginal, que fueron analizadas por técnicas clásicas de microscopía y cultivo corriente y reacción de polimerasa en cadena para Neisseria gonorrhoeae, Trichomonas vaginalis y Chlamydia trachomatis. Resultados: Se encontró 12,9% de infección por C. trachomatis, 2,4% de T. vaginalis. En este estudio no se encontró N. gonorrhoeae. El 23,3% de pacientes con microbiota alterada (vaginosis bacteriana y microbiota intermedia) fue positiva para C. trachomatis. Conclusión: En este trabajo, encontramos una alta frecuencia de infección por C. trachomatis, que se relaciona en forma significativa con la presencia de microbiota alterada. Esta alta frecuencia debería promover estrategias preventivas en los controles de salud de la mujer embarazada.


Background: Pregnant woman is exposed to many sexual transmitted infections (STI). Many of these infections may produce diseases in the fetus and newborn, and also alteration in the normal course of the pregnancy. Aim: Screening of asymptomatic cervical infection in pregnant woman and its relationship with the vaginal microbiota. Patients and Methods: 85 pregnant women without clinical cervicitis who consult in the routine pregnant control (47 patients) and women derived from STI service (38 patients). The samples were obtained from the vaginal fund sac and were analyzed with optic microscopy, cultures and PCR of Neisseria gonorrhoeae, Trichomonas vaginalis and Chlamydia trachomatis. Results: 12,9% of the enrolled women were positive for C. trachomatis, 2,4% for T. vaginalis. In this study, we did not found N. gonorrhoeae. We observed 23,3% of patients with altered microbiota (bacterial vaginosis and intermediate microbiota) was positive for C. trachomatis. Conclusions: In this study, we found a high frequency of C. trachomatis infection, that correlates with the presence of altered microbiota. This high frequency would promote preventive strategies in the pregnant women routine controls.


Subject(s)
Humans , Female , Pregnancy , Adolescent , Adult , Young Adult , Trichomonas Infections/microbiology , Trichomonas vaginalis/isolation & purification , Vagina/microbiology , Sexually Transmitted Diseases, Bacterial/diagnosis , Chlamydia Infections/microbiology , Chlamydia trachomatis/isolation & purification , Pregnancy Complications, Infectious/diagnosis , Pregnancy Complications, Infectious/microbiology , Socioeconomic Factors , Trichomonas Infections/diagnosis , Sexually Transmitted Diseases, Bacterial/microbiology , Chlamydia Infections/diagnosis , Mass Screening , Age Distribution , Asymptomatic Infections , Microbiota
10.
BMC Infect Dis ; 18(1): 549, 2018 Nov 06.
Article in English | MEDLINE | ID: mdl-30400890

ABSTRACT

BACKGROUND: Screening of curable sexually transmitted infections is frequently oriented towards the diagnosis of chlamydia, gonorrhea, syphilis and trichomoniasis, whereas other pathogens, sometimes associated with similar urogenital syndromes, remain undiagnosed and/or untreated. Some of these pathogens are associated with adverse pregnancy outcomes. METHODS: In a nested case-control study, vaginal swabs from 79 pregnant women, i.e., 28 T. vaginalis-positive (cases) and 51 T. vaginalis-negative (controls), were screened by quantitative PCR for Adenovirus 1 and 2, Cytomegalovirus, Herpes Simplex Virus 1 and 2, Chlamydia trachomatis, Escherichia coli, Haemophilus ducreyi, Mycoplasma genitalium, M. hominis, candidatus M. girerdii, Neisseria gonorrhoeae, Streptococcus agalactiae, Treponema pallidum, Ureaplasma parvum, U. urealyticum, and Candida albicans. Additionally, we determined whether women with pathogens highly associated with T. vaginalis had distinct clinical signs and symptoms compared to women with T. vaginalis mono-infection. RESULTS: M. hominis was independently associated with T. vaginalis (adjusted odds ratio = 6.8, 95% CI: 2.3-19.8). Moreover, M. genitalium and Ca M. girerdii were exclusively detected in women with T. vaginalis (P = 0.002 and P = 0.001), respectively. Four of the six women co-infected with T. vaginalis and Ca M. girerdii complained of vaginal itching, compared to only 4 out of the 22 women infected with T. vaginalis without Ca M. girerdii (P = 0.020). CONCLUSION: We confirm M. hominis as a correlate of T. vaginalis in our population, and the exclusive association of both M. genitalium and Ca. M. girerdii with T. vaginalis. Screening and treatment of these pathogens should be considered.


Subject(s)
Coinfection , Pregnancy Complications, Infectious/epidemiology , Pregnancy Complications, Infectious/microbiology , Sexually Transmitted Diseases/epidemiology , Trichomonas Infections/epidemiology , Trichomonas vaginalis/isolation & purification , Urogenital System/microbiology , Adolescent , Adult , Case-Control Studies , Chlamydia trachomatis/isolation & purification , Coinfection/epidemiology , Coinfection/microbiology , Female , Gonorrhea/epidemiology , Gonorrhea/microbiology , Humans , Kenya/epidemiology , Mycoplasma genitalium/isolation & purification , Neisseria gonorrhoeae/isolation & purification , Pregnancy , Sexually Transmitted Diseases/microbiology , Streptococcus agalactiae/isolation & purification , Syphilis/epidemiology , Syphilis/microbiology , Treponema pallidum/isolation & purification , Trichomonas Infections/microbiology , Young Adult
11.
J Agric Food Chem ; 66(30): 7942-7947, 2018 Aug 01.
Article in English | MEDLINE | ID: mdl-30039703

ABSTRACT

Potato peel, a waste product of the potato processing industry, is high in bioactive compounds. We investigated the in vitro antitrichomonad activity of potato peel powders prepared from commercial Russet, red, purple, and fingerling varieties as well as several known potato components, alkaloids and phenolic compounds, against three pathogenic strains of trichomonads. Trichomonas vaginalis is a sexually transmitted protozoan parasite that causes the human disease trichomoniasis. Two distinct strains of the related Tritrichomonas fetus infect cattle and cats. The glycoalkaloids α-chaconine and α-solanine were highly active against all parasite lines, while their common aglycone solanidine was only mildly inhibitory. α-Solanine was several times more active than α-chaconine. The phenolic compounds caffeic and chlorogenic acids and quercetin were mildly active against the parasites. Most of the potato peel samples were at least somewhat active against all three trichomonad species, but their activities were wide-ranging and did not correspond to their glycoalkaloid and phenolic content determined by HPLC. The two Russet samples were the most active against all three parasites. The purple potato peel sample was highly active against bovine and mostly inactive against feline trichomonads. None of the test substances were inhibitory toward several normal microflora species, suggesting the potential use of the peels for targeted therapeutic treatments against trichomonads.


Subject(s)
Alkaloids/pharmacology , Antiprotozoal Agents/pharmacology , Phenols/pharmacology , Plant Extracts/pharmacology , Solanum tuberosum/chemistry , Trichomonas Infections/microbiology , Trichomonas/drug effects , Animals , Cat Diseases/drug therapy , Cat Diseases/parasitology , Cats , Cattle , Cattle Diseases/drug therapy , Cattle Diseases/parasitology , Chromatography, High Pressure Liquid , Plant Tubers/chemistry , Trichomonas/growth & development , Trichomonas Infections/drug therapy
12.
Am J Obstet Gynecol ; 218(3): 328.e1-328.e13, 2018 03.
Article in English | MEDLINE | ID: mdl-29247635

ABSTRACT

BACKGROUND: Trichomonas vaginalis is the most common nonviral sexually transmitted infection. However, because it is not a reportable disease in the United States, there is limited information on the age of infected individuals and their geographic distribution. OBJECTIVE: The purpose of this study was to evaluate the detection rates of T vaginalis infection compared with Chlamydia trachomatis by age and state in a commercial laboratory setting. STUDY DESIGN: Quantitative real-time polymerase chain reactions were used to detect the presence of T vaginalis and C trachomatis in cervicovaginal samples that were obtained during gynecologic examinations. A total of 1,554,966 and 1,999,077 samples from females 10-79 years old were analyzed retrospectively for the presence of T vaginalis and C trachomatis, respectively. RESULTS: The highest detection rate of an infection with T vaginalis was ages 47-53 years. For C trachomatis, the highest detection rate was ages 14-20 years. T vaginalis detection rate distribution by age shows a bimodal pattern with first peak at ages 21-22 years (4.0-4.1%) and a higher second peak at ages 48-51 years (5.4-5.8%). C trachomatis prevalence distribution by age shows a maximum peak of 8.6% at age 17 years and a rapid decline thereafter. In general, the detection rates of both pathogens were higher in the southeast and in states along the Mississippi River Valley than in other parts of the country. A nucleotide polymorphism associated with T vaginalis metronidazole resistance (ntr6TVK80STOP) was not associated with age and was found most frequently in specimens from New Mexico and Vermont. CONCLUSIONS: The detection rate of T vaginalis does not appear to decrease with age as observed for C trachomatis and reaches maximum rates in women 48-51 years old. The geographic distribution of T vaginalis appears to be broadly similar to that of other sexually transmitted diseases. The ntr6TVK80STOP polymorphism did not have a specific association with age or geography.


Subject(s)
Chlamydia Infections/epidemiology , Chlamydia trachomatis , Trichomonas Infections/epidemiology , Trichomonas vaginalis , Adolescent , Adult , Age Distribution , Aged , Anti-Infective Agents/pharmacology , Child , Chlamydia Infections/microbiology , Drug Resistance, Bacterial/genetics , Female , Humans , Metronidazole/pharmacology , Middle Aged , Perimenopause , Polymorphism, Genetic , Premenopause , Prevalence , Real-Time Polymerase Chain Reaction , Retrospective Studies , Trichomonas Infections/microbiology , Trichomonas vaginalis/genetics , United States/epidemiology , Young Adult
13.
Sex Transm Infect ; 94(2): 93-99, 2018 03.
Article in English | MEDLINE | ID: mdl-28798195

ABSTRACT

BACKGROUND: Highly sensitive, commercial nucleic acid amplification tests (NAAT) for Trichomonas vaginalis have only recently been recommended for use in the UK. While testing for T. vaginalis is routine in symptomatic women attending genitourinary medicine (GUM) clinics, it is rare in asymptomatic women or those attending primary care. The aim of this study was to evaluate the positivity of T. vaginalis using a commercial NAAT, in symptomatic and asymptomatic women undergoing testing for chlamydia and gonorrhoea in GUM and primary care settings. METHODS: Samples from 9186 women undergoing chlamydia and gonorrhoea testing in South West England between May 2013 and Jan 2015 were also tested for T. vaginalis by NAAT alongside existing tests. RESULTS: T. vaginalis positivity using NAAT was as follows: in GUM 4.5% (24/530, symptomatic) and 1.7% (27/1584, asymptomatic); in primary care 2.7% (94/3499, symptomatic) and 1.2% (41/3573, asymptomatic). Multivariable regression found that in GUM older age, black ethnicity and deprivation were independent risk factors for T. vaginalis infection. Older age and deprivation were also risk factors in primary care. Testing women presenting with symptoms in GUM and primary care using TV NAATs is estimated to cost £260 per positive case diagnosed compared with £716 using current microbiological tests. CONCLUSIONS: Aptima TV outperforms existing testing methods used to identify T. vaginalis infection in this population. An NAAT should be used when testing for T. vaginalis in women who present for testing with symptoms in primary care and GUM, based on test performance and cost.


Subject(s)
Chlamydia trachomatis/isolation & purification , Neisseria gonorrhoeae/isolation & purification , Trichomonas Infections/diagnosis , Trichomonas vaginalis/isolation & purification , Adolescent , Adult , Aged , Aged, 80 and over , Ambulatory Care Facilities/statistics & numerical data , Asymptomatic Infections/epidemiology , Chlamydia Infections/diagnosis , Chlamydia Infections/epidemiology , Chlamydia Infections/microbiology , Chlamydia trachomatis/genetics , Cross-Sectional Studies , England/epidemiology , Female , Gonorrhea/diagnosis , Gonorrhea/epidemiology , Gonorrhea/microbiology , Humans , Middle Aged , Molecular Diagnostic Techniques , Neisseria gonorrhoeae/genetics , Nucleic Acid Amplification Techniques , Primary Health Care/statistics & numerical data , Regression Analysis , Risk Factors , Trichomonas Infections/epidemiology , Trichomonas Infections/microbiology , Trichomonas vaginalis/genetics , Young Adult
14.
J Med Microbiol ; 66(10): 1436-1442, 2017 Oct.
Article in English | MEDLINE | ID: mdl-28972465

ABSTRACT

PURPOSE: Purulent or exudative genitourinary infections are a frequent cause of consultation in primary and specialized healthcare. The objectives of this study were: to determine the prevalence of Trichomonas vaginalis and co-infections with Candida spp. and Gardnerella vaginalis in vaginal secretion; and to use multilocus sequence typing (MLST) to analyse the genetic diversity of T. vaginalis strains. METHODOLOGY: The samples were submitted for analysis (n=5230) to a third-level hospital in Granada (Southern Spain) between 2011 and 2014; eight T. vaginalis strains isolated during 2015 were randomly selected for MLST analysis. Culture and nucleic acid hybridization techniques were used to detect microorganisms in the samples. RESULTS: The prevalence of T. vaginalis was 2.4 % between 2011 and 2014, being higher during the first few months of both 2011 and 2012. Among samples positive for T. vaginalis, co-infection with G. vaginalis was detected in 29 samples and co-infection with Candida spp. in 6, while co-infection with all three pathogens was observed in 3 samples. The only statistically significant between-year difference in co-infection rates was observed for T. vaginalis with G. vaginalis due to an elevated rate in 2011. MLST analysis results demonstrated a high genetic variability among strains circulating in our setting. CONCLUSION: These findings emphasize the need for the routine application of diagnostic procedures to avoid the spread of this sexually transmitted infection.


Subject(s)
Candida/classification , Candidiasis/complications , Gardnerella vaginalis/isolation & purification , Genetic Variation , Trichomonas Infections/microbiology , Trichomonas vaginalis/genetics , Adolescent , Adult , Aged , Aged, 80 and over , Candidiasis/epidemiology , Coinfection/epidemiology , Coinfection/microbiology , Coinfection/parasitology , Female , Gram-Positive Bacterial Infections/complications , Gram-Positive Bacterial Infections/epidemiology , Gram-Positive Bacterial Infections/microbiology , Humans , Middle Aged , Spain/epidemiology , Trichomonas Infections/complications , Trichomonas Infections/epidemiology , Vaginal Diseases/epidemiology , Vaginal Diseases/microbiology , Vaginal Diseases/parasitology , Young Adult
15.
Enferm. infecc. microbiol. clín. (Ed. impr.) ; 35(supl.3): 58-63, oct. 2017.
Article in Spanish | IBECS | ID: ibc-170751

ABSTRACT

Las infecciones de transmisión sexual precisan para su control de pruebas diagnósticas rápidas, fiables y que permitan su realización en situaciones de cribado. Las técnicas de biología molecular han supuesto una verdadera revolución diagnóstica. Debido a su elevada sensibilidad, no solo detectan más infecciones, sino que permiten la obtención de muestras poco invasivas que facilitan los programas de cribado y evitan el rechazo de los pacientes a la realización de toma de muestras. La mejora de su especificidad evita en muchos casos la realización de pruebas de confirmación, bajo la premisa del cumplimiento de normas de calidad. También permiten diagnosticar patógenos que las técnicas de cultivo son incapaces de recuperar, y cada vez tenemos plataformas diagnósticas más sencillas, versátiles y en formato múltiple que agilizan el trabajo en el laboratorio e incluso fuera de él (AU)


Sexually transmitted infections (STI) require rapid, reliable diagnostic tests that can be performed in screening situations. Molecular biology techniques have been a true diagnostic revolution. Due to their high sensitivity, they detect more infections and allow non-invasive sample collection, simplifying screening programs and minimising patient refusal to have samples taken. Improvements in specificity have reduced the need for confirmation tests in many cases, under the premise of compliance with quality standards. They also allow to identify pathogens that culture techniques are unable to recover. Moreover, diagnostic platforms are increasingly simple, versatile and available in multiplex format, facilitating work inside and outside the laboratory (AU)


Subject(s)
Humans , Sexually Transmitted Diseases/diagnosis , Molecular Biology/methods , Sensitivity and Specificity , Mycoplasma Infections/diagnosis , Mycoplasma Infections/microbiology , Neisseria gonorrhoeae/isolation & purification , Chlamydia trachomatis/isolation & purification , Syphilis Serodiagnosis/methods , Syphilis/diagnosis , Syphilis/microbiology , Granuloma Inguinale/microbiology , Chancroid/microbiology , Herpes Genitalis/microbiology , Trichomonas Infections/microbiology , Candidiasis, Vulvovaginal/microbiology
16.
BMC Complement Altern Med ; 17(1): 461, 2017 Sep 13.
Article in English | MEDLINE | ID: mdl-28903731

ABSTRACT

BACKGROUND: Plants produce secondary metabolites that often possess widespread bioactivity, and are then known as phytochemicals. We previously determined that several phytochemical-rich food-derived preparations were active against pathogenic foodborne bacteria. Trichomonads produce disease (trichomoniasis) in humans and in certain animals. Trichomonads are increasingly becoming resistant to conventional modes of treatment. It is of interest to test bioactive, natural compounds for efficacy against these pathogens. METHODS: Using a cell assay, black tea, green tea, grape, pomegranate, and jujube extracts, as well as whole dried jujube were tested against three trichomonads: Trichomonas vaginalis strain G3 (found in humans), Tritrichomonas foetus strain D1 (found in cattle), and Tritrichomonas foetus-like organism strain C1 (found in cats). The most effective of the test substances was subsequently tested against two metronidazole-resistant Trichomonas vaginalis strains, and on normal mucosal flora. RESULTS: Black tea extract inhibited all the tested trichomonads, but was most effective against the T. vaginalis organisms. Inhibition by black tea was correlated with the total and individual theaflavin content of the two tea extracts determined by HPLC. Metronidazole-resistant Trichomonas vaginalis strains were also inhibited by the black tea extract. The response of the organisms to the remaining preparations was variable and unique. We observed no effect of the black tea extract on common normal flora bacteria. CONCLUSIONS: The results suggest that the black tea, and to a lesser degree green tea, grape seed, and pomegranate extracts might present possible natural alternative therapeutic agents to treat Trichomonas vaginalis infections in humans and the related trichomonad infections in animals, without negatively affecting the normal flora.


Subject(s)
Cat Diseases/microbiology , Cattle Diseases/microbiology , Phytochemicals/pharmacology , Plant Extracts/pharmacology , Trichomonas Infections/microbiology , Trichomonas Infections/veterinary , Trichomonas vaginalis/drug effects , Tritrichomonas foetus/drug effects , Animals , Camellia sinensis/chemistry , Cats , Cattle , Humans , Lythraceae/chemistry , Microbial Viability/drug effects , Trichomonas vaginalis/genetics , Trichomonas vaginalis/growth & development , Trichomonas vaginalis/isolation & purification , Tritrichomonas foetus/genetics , Tritrichomonas foetus/growth & development , Tritrichomonas foetus/isolation & purification , Vitis/chemistry , Ziziphus/chemistry
17.
BMJ Open ; 7(7): e013486, 2017 Aug 01.
Article in English | MEDLINE | ID: mdl-28765124

ABSTRACT

OBJECTIVES: Demographic and risky sexual behaviours may increase the risk for Trichomonas vaginalis (TV) infection and, thus, enhance HIV transmission to uninfected partners. We assessed the demographic and behavioural risk factors associated with TV among South African HIV-positive men with genital ulcer disease. METHODS: We conducted a cross-sectional study with data from a randomised controlled trial conducted by the Centers for Disease Control and Prevention and the London School of Hygiene and Tropical Medicine. The data were obtained from three primary healthcare clinics in South Africa. At baseline (n=387), participants reported on demographics, sexual behaviour, history of sexually transmitted infections and clinical ulcers. The outcome TV was measured using real-time multiplex PCR assays and a Rotor-gene 3000 platform from the first and past urine samples of all participants. Logistic regression model estimated ORs and 95% CIs adjusted for demographics, sexual risk behaviours and ulcer conditions. RESULTS: An estimated 11.4% of TV was detected among the men. The odds of TV infection were significantly associated with high blister counts (OR 4.0, 95% CI 1.6 to 28, p=0.01), ulcer pain (OR 0.4, 95% CI 0.2 to 0.7, p=0.003), number of days with ulcers (OR 0.4, 95% CI 0.2 to 0.8, p=0.006), sought treatment before coming into clinics (OR 0.07, 95% CI 0.002 to 0.7, p=0.005) and being unqualified worker (OR 2.5, 95% CI 0.9 to 6.7 p=0.05). Multivariate analyses revealed that increased days with ulcers (OR 0.1, 95% CI 0.04 to 0.5, p=0.002) and ulcer pain intensity (OR 0.08, 95% CI 0.007 to 1.1, p=0.05) remained significantly associated with decreased odds of TV infection. Men from the Sotho ethnic group were eight times more likely to have TV infection (OR 8.6, 95% CI 1.3 to 55.7, p<0.02) than men from the other ethnic groups. CONCLUSION: HIV-positive men with severe ulceration should be screened and treated for TV to minimise HIV transmission to uninfected partners.


Subject(s)
Genitalia/microbiology , HIV Infections , Male Urogenital Diseases/microbiology , Risk-Taking , Sexual Behavior , Trichomonas Infections/etiology , Trichomonas vaginalis/growth & development , Adolescent , Adult , Cross-Sectional Studies , Demography , Ethnicity , Genitalia/pathology , HIV Infections/transmission , Humans , Male , Male Urogenital Diseases/ethnology , Male Urogenital Diseases/etiology , Male Urogenital Diseases/pathology , Multivariate Analysis , Odds Ratio , Prevalence , Risk Factors , Sexually Transmitted Diseases , South Africa , Trichomonas Infections/ethnology , Trichomonas Infections/microbiology , Trichomonas Infections/pathology , Ulcer , Young Adult
18.
Sci Rep ; 7(1): 3764, 2017 06 19.
Article in English | MEDLINE | ID: mdl-28630471

ABSTRACT

Genital mycoplasmas, which can be vertically transmitted, have been implicated in preterm birth, neonatal infections, and chronic lung disease of prematurity. Our prior work uncovered 16S rRNA genes belonging to a novel, as-yet-uncultivated mycoplasma (lineage 'Mnola') in the oral cavity of a premature neonate. Here, we characterize the organism's associated community, growth status, metabolic potential, and population diversity. Sequencing of genomic DNA from the infant's saliva yielded 1.44 Gbp of high-quality, non-human read data, from which we recovered three essentially complete (including 'Mnola') and three partial draft genomes (including Trichomonas vaginalis). The completed 629,409-bp 'Mnola' genome (Candidatus Mycoplasma girerdii str. UC-B3) was distinct at the strain level from its closest relative, vaginally-derived Ca. M. girerdii str. VCU-M1, which is also associated with T. vaginalis. Replication rate measurements indicated growth of str. UC-B3 within the infant. Genes encoding surface-associated proteins and restriction-modification systems were especially diverse within and between strains. In UC-B3, the population genetic underpinnings of phase variable expression were evident in vivo. Unique among mycoplasmas, Ca. M. girerdii encodes pyruvate-ferredoxin oxidoreductase and may be sensitive to metronidazole. This study reveals a metabolically unique mycoplasma colonizing a premature neonate, and establishes the value of genome-resolved metagenomics in tracking phase variation.


Subject(s)
Mouth , Mycoplasma Infections , Mycoplasma , Trichomonas Infections , Trichomonas vaginalis , Female , Humans , Infant, Newborn , Male , Mouth/microbiology , Mouth/pathology , Mycoplasma/genetics , Mycoplasma/growth & development , Mycoplasma Infections/genetics , Mycoplasma Infections/metabolism , Mycoplasma Infections/microbiology , Mycoplasma Infections/pathology , Trichomonas Infections/genetics , Trichomonas Infections/metabolism , Trichomonas Infections/microbiology , Trichomonas Infections/pathology , Trichomonas vaginalis/genetics , Trichomonas vaginalis/growth & development
19.
Ethiop J Health Sci ; 27(6): 589-600, 2017 Nov.
Article in English | MEDLINE | ID: mdl-29487468

ABSTRACT

BACKGROUND: Sexually transmitted infection (STI) is a major global cause of acute illness, infertility, long-term disability and death, with serious medical and psychological consequences to millions of men, women and infants. Moreover, in Ethiopia, epidemiological studies on STI among STI clinic clients are limited. Therefore, the aim of this study was to determine the prevalence and associated risk factors of sexually transmitted infection (STI). METHODS: A cross sectional study was conducted between April and August 2014 among STI clinic clients in Gondar Town hospitals and health centers. One hundred twenty study participants who fulfill the criteria were included. Different laboratory methods and techniques were applied to identify the possible microorganisms. Data were entered and analyzed using SPSS version 20. Logistic regression was used to determine risk factors for STI and P values < 0.05 was considered statistically significant. RESULTS: The overall laboratory test confirmed that STIs prevalence was 74.1% with 32.5% being Candida spp., 30% T. palladium, 20.8% N. gonorrhoeae and 14.2% T. vaginalis. Two or more organisms were isolated in 20% of the study subjects. Risk factors for STI had knowledge about STI and alcohol consumption. CONCLUSION: The prevalence of N. gonorrhoeae, T. pallidum, T. vaginalis, and Candida spp. in the study area was high. It needs health education programs, promotes condom utilization and more comprehensive community based STI studies.


Subject(s)
Chlamydia Infections/epidemiology , Gonorrhea/epidemiology , Syphilis/epidemiology , Trichomonas Infections/epidemiology , Adolescent , Adult , Ambulatory Care Facilities , Chlamydia Infections/microbiology , Chlamydia trachomatis/growth & development , Cross-Sectional Studies , Ethiopia/epidemiology , Female , Gonorrhea/microbiology , Hospitals , Humans , Male , Middle Aged , Neisseria gonorrhoeae/growth & development , Prevalence , Risk Factors , Sexually Transmitted Diseases , Syphilis/microbiology , Treponema pallidum/growth & development , Trichomonas Infections/microbiology , Trichomonas vaginalis/growth & development , Young Adult
20.
Expert Rev Anti Infect Ther ; 15(2): 133-145, 2017 02.
Article in English | MEDLINE | ID: mdl-27894204

ABSTRACT

INTRODUCTION: Mycoplasma genitalium is an emerging agent of sexually-transmitted infection and is responsible for clinically-significant genital tract disease in both females and males. Similar to scenarios recently experienced with the urogenital flagellate Trichomonas vaginalis, an evolving molecular diagnostic reference standard based on transcription-mediated amplification allows for accurate detection of the organism, plus additional insight into disease epidemiology. Areas covered. The basis for this article includes primary peer-reviewed literature plus compilations of data derived from routine clinical laboratory screening of females and males for agents of sexually-transmitted infection. Introductory laboratory and epidemiologic data related to T. vaginalis provides not only a foreshadowing to the dichotomies inherent to M. genitalium prevalence but also advocacy of a common non-invasive specimen source that could be used to screen females for both agents. This review also documents increased prevalence rates of M. genitalium in both females and males by way of transcription-mediated amplification. Expert commentary. Molecular detection of M. genitalium should be a consideration in the development of comprehensive sexually-transmitted infection screening programs for both females and males. Transcription-mediated amplification has additionally identified novel facets of M. genitalium and T. vaginalis epidemiology that warrant further investigation.


Subject(s)
Mycoplasma Infections/epidemiology , Mycoplasma genitalium/isolation & purification , Sexually Transmitted Diseases/epidemiology , Trichomonas Infections/epidemiology , Trichomonas vaginalis/isolation & purification , Female , Humans , Male , Mass Screening , Mycoplasma Infections/microbiology , Mycoplasma genitalium/genetics , Prevalence , Sexually Transmitted Diseases/microbiology , Trichomonas Infections/microbiology , Trichomonas vaginalis/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...